Repositorio Dspace

Listar por autor "Rabasco, Cristina"

Listar por autor "Rabasco, Cristina"

Ordenar por:Orden:Resultados:

  • Caravaca-Fontan, Fernando; Cavero, Teresa; Díaz-Encarnación, Montserrat; Cabello, Virginia; Ariceta, G; Quintana, Luis-F; Marco, Helena; Barros, Xoana; Ramos, Natalia; Rodríguez-Mendiola, Nuria; Cruz, Sonia; Fernández-Juarez, Gema; Rodríguez, Adela; Pérez-de-Jose, Ana; Rabasco, Cristina; Rodado, Raquel; Fernández, Loreto; Pérez-Gómez, Vanessa; Ávila, Ana; Bravo, Luis; Espinosa, Natalia; Allende, Natalia; Sánchez-de-la-Nieta, María-Dolores; Rodríguez, Eva; Rivas-Becerra, Begoña; Melgosa, Marta; Huerta, Ana; Miquel, Rosa; Mon, Carmen; Fraga, Gloria; de-Lorenzo, Alberto; Draibe, Juliana; González, Fayna; Shabaka, Amir; López-Rubio, María-Esperanza; Fenollosa, María-Ángeles; Martín-Penagos, Luis; Da-Silva, Iara; Alonso-Titos, Juana; Rodríguez-de-Cordoba, Santiago; Goicoechea-de-Jorge, Elena; Praga, Manuel (AMER SOC NEPHROLOGY, 2023-05)
    KEY POINTS: Kidney survival in C3 glomerulopathy is significantly higher in patients with a disease chronicity score <4 and proteinuria <3.5 g/d, regardless of baseline eGFR. A faster eGFR decline in C3 glomerulopathy is ...
  • Huerta, Ana; López-Sánchez, Paula; Martínez, Eduardo; Quintana, Luis-F; Martin-Gómez, Adoracion; Lopes, Vanessa; Rabasco, Cristina; Rodríguez, Jorge-Alberto; Rodríguez, Celia; Temprado, Alba; López-Mendoza, Manuel; Borrego, Francisco-José; Afonso, Sara; Rodríguez, Antolina; Fernández, Loreto; Gago, María; Prados, María-del-Carmen; Gracia, Olga; Sierra, Milagros; Sánchez-Agesta, Marina; Carbayo, Javier; Hadad-Arrascue, Fernando; Romera, Ana; Cox, Roger; Mora, José-María; Rivas, Begona; Fernández-Solis, Juan; Gómez-Preciado, Francisco; Mora, María-Teresa; Marquez, Eva; Espino, Mar; Larramendi, Carmen; López-Corbeto, Mireia; Devolder-Nicolau, Adriana; Puente-García, Adriana; Shabaka, Amir; González, Sara; Martin, Carmen; Mon, Carmen; Tato, Ana; Villa, Daniel; Galindo, María; Martin-Testillano, Lucía; Portoles, José; Morales, Enrique (FRONTIERS MEDIA SA, 2026-08-25)
    OBJECTIVES: Belimumab has emerged as a therapeutic option for lupus nephritis (LN); however, real-world evidence on its effectiveness remains limited. This study aimed to evaluate the effectiveness and safety of belimumab ...